TMEM51-AS2: A Promising Protein Target Or Biomarker (G727684)

Target Name: TMEM51-AS2

NCBI ID: G727684

TMEM51-AS2

TMEM51-AS2: A Promising Protein Target Or Biomarker

TMEM51-AS2 (C1orf195 variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the transmembrane protein family and is known for its role in cell signaling and inflammation.

In recent years, researchers have been interested in investigating TMEM51-AS2 as a potential drug target or biomarker. This is because the protein has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key studies that has explored TMEM51-AS2 as a potential drug target is a mouse model of cancer. Researchers found that TMEM51-AS2 was highly expressed in cancer cells and that inhibiting the protein's activity could significantly reduce the growth of these cells.

Another study that has investigated TMEM51-AS2 as a potential biomarker is a study of individuals with neurodegenerative diseases. The researchers found that TMEM51-AS2 was highly expressed in the brains of individuals with Alzheimer's disease and that reducing the protein's activity may be a promising approach to treating this disease.

In addition to its potential as a drug target or biomarker, TMEM51-AS2 is also of interest as a potential therapeutic target for a variety of other diseases. For example, the protein has been shown to play a role in the development and progression of autoimmune disorders, and may be a useful target for treating these conditions.

Overall, TMEM51-AS2 is a protein that has generated a lot of interest in recent years as a potential drug target or biomarker. Further research is needed to fully understand its role in these diseases and to explore its potential as a therapeutic target.

Protein Name: TMEM51 Antisense RNA 2

The "TMEM51-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM51-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets